TherapeuticsMD (TXMD) Provides Update on Third Quarter Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. FLG
4. META
5. FICO
6. GMAB
7. ACCV
8. LLY
9. TSLA
10. SPCX

Go back to TherapeuticsMD (TXMD) Provides Update on Third Quarter Progress

TherapeuticsMD Provides Update on Third Quarter Progress

September 25, 2020 9:02 AM EDT

-Company believes industry prescription tracking databases are not accurately tracking ANNOVERA®-

-Underlying retail and wholesale demand for ANNOVERA is strong and growing-

-Company experiencing record retail and wholesale growth for ANNOVERA-

BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative womens healthcare company, today announced that the Company is on track to meet or exceed third quarter 2020 total net revenue consensus of $15.1 million. For the Companys ANNOVERA (segesterone acetate and ethinyl estradiol vaginal system) product, the Company has seen... More